Immuneering Corporation (IMRX) Tops Q2 EPS by 2c
Tweet
Share
E-mail
Get Alerts IMRX Hot Sheet
Join SI Premium – FREE
Immuneering Corporation (NASDAQ: IMRX) reported Q2 EPS of ($0.40), $0.02 better than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
